Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- RNO.AU
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Rhinomed Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 11.47M
- Ent value
- -
- Price/Sales
- 0.84
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 0.42%
- 1 year return
- -55.56%
- 3 year return
- -31.60%
- 5 year return
- -29.21%
- 10 year return
- -37.06%
Last updated: 2024-12-17
DIVIDENDS
RNO.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.84 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 286.78M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 13.62M |
| Gross profit (TTM) | 5.11M |
| Operating income (TTM) | -7.86M |
| Net income (TTM) | -14.04M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 37.53% |
| Operating margin (TTM) | -57.67% |
| Profit margin (TTM) | -103.03% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.96M |
| Net receivables | 0.00 |
| Total current assets | 1.96M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 0.00 |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -13.01M |
| Capital expenditures (TTM) | 123.19K |
| Free cash flow (TTM) | -13.13M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| RNO.AU | S&P500 | |
| Current price drop from All-time high | -99.98% | -0.50% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 20 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -92.37% | -11.12% |
| Avg time to new high | 1729 days | 12 days |
| Max time to new high | 3456 days | 1805 days |
COMPANY DETAILS
Marketcap
11.47M
Marketcap category
Small-cap
Description
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. The company offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. Its products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. The company also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found